Section I
781 – 790 of 4726
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Evaluating the therapeutic efficacy of mono-and bivalent affibody-based fusion proteins targeting HER3 in a pancreatic cancer xenograft model
(
- Contribution to journal › Article
-
Mark
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
(
- Contribution to journal › Article
-
Mark
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care
(
- Contribution to journal › Article
-
Mark
Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting
(
- Contribution to journal › Article
-
Mark
Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8+ T cells in non-melanoma cancers compared to melanoma
(
- Contribution to journal › Article
-
Mark
Grain and dietary fiber intake and bladder cancer risk : a pooled analysis of prospective cohort studies
(
- Contribution to journal › Article
-
Mark
Ny definition av palliativ vård med fokus på lidande
(
- Contribution to journal › Letter
-
Mark
High-dose naloxone : Effects by late administration on pain and hyperalgesia following a human heat injury model. A randomized, double-blind, placebo-controlled, crossover trial with an enriched enrollment design
(
- Contribution to journal › Article
-
Mark
Mammographic tumour appearance is related to clinicopathological factors and surrogate molecular breast cancer subtype
(
- Contribution to journal › Article